BRAIN PATHOLOGY
Scope & Guideline
Unveiling Innovations in Brain Pathology
Introduction
Aims and Scopes
- Neurodegenerative Diseases:
Research often explores the molecular and cellular mechanisms underlying neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS). This includes studies on proteinopathies, synaptic dysfunction, and neuroinflammation. - Tumor Pathology:
A significant focus is placed on brain tumors, including gliomas and meningiomas, with an emphasis on histopathological classification, molecular profiling, and prognostic factors. The journal highlights advances in diagnostic approaches and treatment strategies. - Neuroinflammation and Immune Response:
The journal addresses the role of neuroinflammation in various neurological conditions, examining the interplay between the immune system and neural cells, and how these interactions contribute to disease progression. - Advanced Imaging and Diagnostic Techniques:
BRAIN PATHOLOGY publishes studies utilizing cutting-edge imaging technologies and molecular diagnostics, including MRI, PET scans, and next-generation sequencing, to enhance disease classification and understanding. - Genetic and Epigenetic Factors:
Research on genetic mutations, epigenetic modifications, and their contributions to brain pathology is prominent. This includes investigations into hereditary conditions, tumor genetics, and the role of environmental factors. - Clinical Correlation and Biomarkers:
The journal emphasizes the importance of correlating clinical findings with pathological data, aiming to identify biomarkers for early diagnosis and prognosis of neurological disorders.
Trending and Emerging
- Multi-Omics Approaches:
Recent studies increasingly employ multi-omics strategies, integrating genomics, transcriptomics, and proteomics to provide comprehensive insights into brain pathologies, facilitating the discovery of novel biomarkers and therapeutic targets. - Artificial Intelligence in Diagnostics:
There is a surge in the application of artificial intelligence and machine learning techniques for diagnostic purposes, particularly in analyzing histopathological data and imaging, enhancing accuracy and efficiency in disease classification. - Neurovascular Contributions to Disease:
Emerging research highlights the role of neurovascular dysfunction in neurodegenerative diseases and brain tumors, focusing on how vascular health impacts neuronal integrity and pathology. - Microbiome-Brain Interactions:
An increasing number of studies are exploring the relationship between the gut microbiome and brain health, investigating how microbial factors may influence neuroinflammation and neurodegeneration. - Therapeutic Targeting of Inflammation:
There is a growing interest in targeting neuroinflammatory pathways as potential therapeutic strategies for various neurological disorders, with research focusing on the modulation of immune responses in the brain. - Longitudinal Studies and Biomarker Development:
There is an emerging trend towards longitudinal studies that track disease progression over time, aiming to identify early biomarkers and therapeutic windows for intervention in neurodegenerative diseases.
Declining or Waning
- Traditional Histopathology:
There appears to be a waning focus on traditional histopathological techniques without molecular integration. As the field moves towards more advanced molecular and imaging techniques, basic histopathological studies are becoming less prominent. - Single Disease Focus Studies:
There is a noticeable decline in studies that focus solely on single disease entities without considering comorbidities or overlapping pathologies. The trend is shifting towards a more integrated approach that examines multiple conditions. - Animal Models in Isolation:
While animal models remain crucial for research, there is a reduced emphasis on studies that do not translate findings to human pathology or clinical applications, indicating a desire for more clinically relevant research.
Similar Journals
NATURE NEUROSCIENCE
Leading the Way in Cutting-Edge Neuroscience ResearchNATURE NEUROSCIENCE is a premier journal published by NATURE PORTFOLIO, focusing on cutting-edge research in the field of neuroscience. With an esteemed impact factor that reflects its significance in the academic community, this journal occupies an exceptional place in the 2023 Q1 category for neuroscience (miscellaneous) and boasts a leading Scopus rank of #1 out of 113 in general neuroscience, placing it within the top 1st percentile. Since its inception in 1998, NATURE NEUROSCIENCE has consistently delivered high-quality, peer-reviewed articles that contribute to our understanding of the nervous system, driving innovation and scholarship across disciplines. Although it does not offer open access, the journal remains a vital resource for researchers, professionals, and students seeking to stay at the forefront of neuroscientific discovery and discussion. Its editorial commitment to excellence ensures that it continually shapes the trajectory of neuroscience research well into 2024 and beyond, making it an indispensable asset for anyone passionate about the brain and its complexities.
ADVANCES IN ANATOMIC PATHOLOGY
Advancing the Frontiers of Anatomical Insights.ADVANCES IN ANATOMIC PATHOLOGY is a leading peer-reviewed journal dedicated to the field of anatomical pathology, published by LIPPINCOTT WILLIAMS & WILKINS. With an impressive impact factor and consistent ranking in the Q1 category for both Anatomy and Pathology and Forensic Medicine, it serves as an essential resource for researchers, clinicians, and students alike. The journal has been a critical platform for disseminating significant findings and advancements in the discipline since its inception in 1996, boasting Scopus rankings of #1 in Anatomy and #11 in Pathology. While it does not provide open access, it maintains rigorous standards in the selection of articles, ensuring that published research reflects the latest developments and techniques in the field. As we look toward 2024 and beyond, ADVANCES IN ANATOMIC PATHOLOGY remains committed to advancing the science of pathology, fostering innovation, and enhancing clinical practice through impactful research.
PATHOLOGY INTERNATIONAL
Exploring the Depths of Pathological SciencePATHOLOGY INTERNATIONAL, published by WILEY, stands as a distinguished journal in the field of pathology and forensic medicine, serving as an essential resource for researchers, clinicians, and students alike. With its ISSN 1320-5463 and E-ISSN 1440-1827, PATHOLOGY INTERNATIONAL has established itself since its inception in 1951, navigating through an evolving landscape in medical science with insights and breakthroughs up to 2024. It holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pathology and Forensic Medicine categories, indicating its robust influence and quality within these fields, as evidenced by its placement in the 70th percentile of Scopus rankings. While currently not an open-access journal, it provides access options that ensure valuable research remains available to the academic community. PATHOLOGY INTERNATIONAL commits to advancing the discipline through pioneering research articles, comprehensive reviews, and expert opinions that push the boundaries of understanding in pathology, thereby supporting the enhancement of diagnostic and therapeutic practices.
Biological Psychiatry
Pioneering research that bridges biological science and psychiatric practice.Biological Psychiatry is a premier journal dedicated to advancing the understanding of the biological underpinnings of psychiatric disorders. Published by Elsevier Science Inc, this esteemed journal is recognized globally for its rigorous peer-reviewed research and contributes significantly to the field of biological psychiatry. With an impressive impact factor that places it in Q1 of its category and ranks 3rd out of 51 in Neuroscience Biological Psychiatry, it reflects the journal's strength in disseminating high-quality findings that push the boundaries of knowledge. Since its inception in 1969, the journal has undergone continuous evolution, aiming to integrate biological and clinical perspectives to optimize the understanding of mental health conditions. Although it does not offer open access, Biological Psychiatry serves as a critical resource for researchers, practitioners, and students, offering insights that influence both theoretical frameworks and practical applications in the realm of psychiatric science.
ACTA NEUROPATHOLOGICA
Leading the Charge in Impactful Neuroscience ResearchACTA NEUROPATHOLOGICA, published by Springer, is a leading journal in the fields of cellular and molecular neuroscience, clinical neurology, and pathology, recognized for its exceptional quality and impactful research. With an impressive impact factor and currently ranked in the Q1 tier across multiple categories in 2023, this journal serves as a premier platform for the dissemination of groundbreaking findings in neuropathology. The journal's robust Scopus rankings highlight its influence, standing at #2 in Pathology and Forensic Medicine and #5 in Clinical Neurology. Since its inception in 1961, ACTA NEUROPATHOLOGICA has provided crucial insights into neurological diseases and disorders, contributing significantly to the advancement of medical science. Aimed at researchers, practitioners, and students alike, this journal fosters a deeper understanding of neurological conditions and encourages innovative approaches within the field. It is essential reading for anyone dedicated to unraveling the complexities of the nervous system.
ENDOCRINE PATHOLOGY
Transforming Knowledge into Clinical PracticeENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.
NEUROSCIENCE RESEARCH
Bridging Inquiry and Insight in NeuroscienceNEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.
Fetal and Pediatric Pathology
Exploring the complexities of fetal and pediatric pathology.Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.
MOLECULAR PSYCHIATRY
Shaping the Future of Psychiatry with Cutting-Edge DiscoveriesMOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.
NEUROBIOLOGY OF AGING
Illuminating the Pathways of Aging and Brain HealthNEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.